NetworkNewsBreaks Archive - Page 1633 of 2268

WednesdayJan 29, 2020 1:45 pm

NetworkNewsBreaks – ChineseInvestors.com Inc. (CIIX) Advancing CBD Initiatives

ChineseInvestors.com (OTCQB: CIIX), a leading financial information website for Chinese-speaking investors in the United States and China, is capitalizing on the rising demand for cannabidiol (“CBD”)-based nutrition and health products. A recent article discussing the company reads, “CIIX’s CBD initiatives are carried out by its subsidiary, CBD Biotech Inc. In essence, CIIX is taking advantage of its own financial expertise to establish itself as a leader in China’s developing CBD industry. Through CBD Biotech, CIIX has established a three-year development plan to capitalize on the union of CBD and the nutrition and health-products market in mainland China. . . .…

WednesdayJan 29, 2020 1:15 pm

NetworkNewsBreaks – Orion Energy Systems, Inc.’s (NASDAQ: OESX) Competitive Position Featured in Roth Equity Research Report

Orion Energy Systems (NASDAQ: OESX) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “Orion announced $18m-$20m incremental purchase indications from Home Depot (HD-NC), bringing the total HD orders to ~$130m. This announcement raises credibility for Orion's competitive position looking to steal one of Acuity's (AYI-Sell) Top-5 customers, where we expect visibility will greatly improve in coming weeks. Home Depot was originally an Acuity customer, and Orion is delivering a fully-custom retrofit package that avoids depreciation charges for the customer, while offering a $40 retrofit solution vs. the $200 Acuity alternative.” To…

WednesdayJan 29, 2020 12:44 pm

NetworkNewsBreaks – Adaptimmune Therapeutics plc (NASDAQ: ADAP) Secures $84M in Underwritten Public Offering

Adaptimmune Therapeutics (NASDAQ: ADAP), a leader in T-cell therapy to treat cancer, has closed an underwritten public offering of 21,000,000 of its American Depositary Shares (“ADSs”). According to the update, Adaptimmune Therapeutics secured gross proceeds of $84 million in the offering, with each of the ADSs sold at the public offering price of $4.00. Adaptimmune has, in connection with the offering, granted the underwriters a 30-day option to purchase up to an additional 3,150,000 ADSs at the public offering price. All ADSs in this offering are sold by Adaptimmune Therapeutics, which intends to use the proceeds to advance the development…

WednesdayJan 29, 2020 12:38 pm

NetworkNewsBreaks – Sharps Compliance Corp.’s (NASDAQ: SMED) Outperformance, Solid Growth Featured in Roth Equity Research Report

Sharps Compliance (NASDAQ: SMED) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “Sharps outperformed across the board as all of its segments posted solid growth. Importantly, Unused Medications and Route-based Collection continued their growth trajectories. These segments provide substantially larger addressable markets, have consistent revenue profiles and are key to future growth and valuation. We anticipate continued 15%+ overall company growth in F2020 with acquisitions potentially aiding Route-based collections by adding customer density.” To view the full report, visit http://nnw.fm/1rpnT About Sharps Compliance Corp. Headquartered in Houston, Texas, Sharps Compliance is…

WednesdayJan 29, 2020 11:53 am

NetworkNewsBreaks – Inovio Pharmaceuticals, Inc. (NASDAQ: INO) to Host Expert Call on Coronavirus Implications Both Near its Source and Closer to Home

Inovio Pharmaceuticals (NASDAQ: INO) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. According to the update, the company intends to host a conference call at 10:30 a.m. EST on Monday, February 3, 2020, during which Dr. David B. Weiner, Ph.D. will discuss implications of the coronavirus epidemic both near its source and closer to home, given the recent outbreak of a new strain in China and its spread to North America. Dr Weiner is executive vice president of the Wistar Institute, director of Vaccine & Immunotherapy Center, and professor emeritus at the University of…

WednesdayJan 29, 2020 11:25 am

NetworkNewsBreaks – QuickLogic Corp (NASDAQ: QUIK) Featured as “Differentiated Sensor Processing and AI Platform Investment Opportunity” in Roth Equity Research Report

QuickLogic Corp (NASDAQ: QUIK) was featured in a recent Equity Research Report Published by Roth Capital Partners, LLC. The report reads, “We believe QUIK represents a differentiated sensor processing and AI platform investment opportunity. We are encouraged by QUIK’s decision to reduce its workforce by nearly one-third. QUIK also provided preliminary reaffirmation of its prior 4Q19 guidance for revenue. We now expect ‘20e growth to results in a closer break-even than prior to the restructuring announcement. We lower our price target from $8.50 to $6.50 and maintain to Neutral.” To view the full report, visit http://nnw.fm/I5t1N About QuickLogic Corp QuickLogic…

WednesdayJan 29, 2020 10:51 am

NetworkNewsBreaks – Sugarmade, Inc. (SGMD) Announces New, Bold Shift in Business Strategy, Eyes On-Demand Revolution of the Cannabis Sector

Sugarmade (OTCQB: SGMD) today announced a new and bold shift in its business strategy toward the virtualization of the cannabis sector as part of the major shift in the U.S. business model toward an on-demand economy. According to the update, Sugarmade will make several strategic moves over the coming weeks as it launches on-demand and related business operations via internally developed initiatives and new relationships with proven sector business operators. “Things are changing in society and in the economy as virtualization proliferates. Many of the most dynamic and innovative growth companies are part of this on-demand revolution and it is…

WednesdayJan 29, 2020 10:15 am

NetworkNewsBreaks – Genprex, Inc. (NASDAQ: GNPX) Announces Independent Research Findings on TUSC2 as a Potential Target and Biomarker for Thyroid Carcinoma

Genprex (NASDAQ: GNPX), a clinical-stage gene therapy company utilizing a unique, non-viral proprietary platform designed to deliver tumor suppressor genes to cancer cells, today announced that, in a recent study, independent researchers reported that TUSC2, a tumor suppressor gene and the active agent in Genprex’s Oncoprex(TM) immunogene therapy, is a potential target and biomarker for thyroid carcinoma. Genprex has no affiliation with these researchers. The study, published in the International Journal of Molecular Sciences, reports that TUSC2 overexpression decreased thyroid cancer proliferation, migration and invasion. “We continue to be encouraged by data resulting from studies conducted at multiple research institutions…

WednesdayJan 29, 2020 9:48 am

NetworkNewsBreaks – HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF) Closes Deal to Purchase Hemp Extraction Company Kase Farma Inc.

HTC Extraction Systems (TSX.V: HTC) (OTCQB: HTPRF), a hemp-biomass processing entity, this morning announced the closing of its previously announced share and purchase agreement (“SPA”) with Starling Brands, Inc., a party at arm's length to HTC, pursuant to which HTC purchased all the issued and outstanding shares of Kase Farma Inc. Kase Farma, which is authorized to operate in the areas of hemp cultivation, extraction, refining and formulation in the State of California, is now a wholly owned subsidiary of HTC. In accordance with the agreement, the company retains the management services of Starling, led by highly regarded experts in…

WednesdayJan 29, 2020 9:30 am

NetworkNewsBreaks – PowerBand Solutions Inc. (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) CEO Enters Voluntary Escrow Agreement; Plans to Hold Shares for Minimum of 12 Months

PowerBand Solutions (TSX.V: PBX) (OTCQB: PWWBF) (FRA: 1ZVA) this morning announced that CEO and largest shareholder Kelly Jennings is entering into a voluntary escrow agreement with Computershare and reported that he will not sell his shares for at least 12 months, until January 29, 2021. This commitment is additional to any escrow imposed by the TSX Venture Exchange. Jennings holds 41,865,283 shares of PowerBand, representing about 37% of the company's outstanding shares. “I want people to know I am invested in PowerBand for the long run as we revolutionize how cars and trucks are bought, sold, leased and auctioned,” PowerBand…

Financial news and publishing for public and private companies

Contact us: 512.354.7000

NetworkNewsBreaks